Ceacam1L modulates STAT3 signaling to control the proliferation of glioblastoma-initiating cells

Cancer Research

Volumn 75, Issue 19, 2015, Pages 4224-4234

  Kaneko, Sadahiro ^a,b   Nakatani, Yuka ^c   Takezaki, Tatsuya ^c,d   Hide, Takuichiro ^c,d   Yamashita, Daisuke ^e   Ohtsu, Naoki ^a   Ohnishi, Takanori ^e   Terasaka, Shunsuke ^b   Houkin, Kiyohiro ^b   Kondo, Toru ^a,c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c RIKEN   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1L; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; UNCLASSIFIED DRUG; CARCINOEMBRYONIC ANTIGEN; CD66 ANTIGENS; CEACAM1 PROTEIN, MOUSE; CELL ADHESION MOLECULE; CSK TYROSINE-PROTEIN KINASE; LEUKOCYTE ANTIGEN; STAT3 PROTEIN, HUMAN; STAT3 PROTEIN, MOUSE; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; GLIOBLASTOMA INITIATING CELL; GROWTH REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; ASTROCYTOMA; BRAIN TUMOR; CANCER STEM CELL; CELL DIVISION; CELL SELF-RENEWAL; DRUG SCREENING; GENE EXPRESSION PROFILING; GENETICS; KAPLAN MEIER METHOD; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; POLYMERIZATION; PROTEIN PROCESSING; PROTEIN TERTIARY STRUCTURE; STEM CELL NICHE; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE; VASCULARIZATION;

ANIMALS; ANTIGENS, CD; ASTROCYTOMA; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION MOLECULES; CELL DIVISION; CELL SELF RENEWAL; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MICE; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; POLYMERIZATION; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; STEM CELL NICHE; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 84945571472     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-0412     Document Type: Article

References (49)

1. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-8.
2. Singh SK, Clarke ID, Hide T, Dirks PB. Cancer stem cells in nervous system tumors. Oncogene 2004;23:7267-73.
3. Kondo T. Brain cancer stem-like cells. Eur J Cancer 2006;42:1237-42.
4. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer 2006;6:425-36.
5. Alvarez-Buylla A, Lois C. Neuronal stem cells in the brain of adult vertebrates. Stem Cells 1995;13:263-72.
6. Frisén J, Johansson CB, Lothian C, Lendahl U. Central nervous system stem cells in the embryo and adult. Cell Mol Life Sci 1998;54:935-45.
7. Hide T, Takezaki T, Nakatani Y, Nakamura H, Kuratsu J, Kondo T. Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation. Cancer Res 2009;69:7953-9.
8. Hide T, Takezaki T, Nakatani Y, Nakamura H, Kuratsu J, Kondo T. Combination of a Ptgs2 inhibitor and an EGFR signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage derived glioma-initiating cells. Stem Cells 2011;29:590-9.
9. Yamashita D, Kondo T, Ohue S, Takahashi H, Ishikawa M, Matoba R, et al. miR-340 acts as a tumor suppressor in tumorigenesis of human gliomainitiating cells by targeting plasminogen activator, tissue. Cancer Res 2015;75:1123-33.
10. Gray-Owen SD, Blumberg RS. CEACAM1: contact-dependent control of immunity. Nat Rev Immunol 2006;6:433-46.
11. Kuespert K, Pils S, Hauck CR. CEACAMs: their role in physiology and pathology. Curr Opin Cell Biol 2006;18:565-71.
12. Nagaishi T, Iijima H, Nakajima A, Chen D, Blumberg RS. Role of CEACAM as a regulator of T cells. Ann NY Acad Sci 2006;1072:155-75.
13. Fuller GN, Bigner SH. Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat. Res 1992;276:299-306.
14. Kondo T, Raff M. Chromatin remodeling and histone modification in the conversion of oligodendrocyte precursors to neural stem cells. Genes Dev 2004;18:2963-72.
15. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A 2004;101:781-6.
16. Thomas M, Klibanov AM. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A 2002;99: 14640-5.
17. Takanaga H, Tsuchida-Straeten N, Nishide K, Watanabe A, Aburatani H, Kondo T. Gli2 is a novel regulator of sox2 expression in telencephalic neuroepithelial cells. Stem Cells 2009;27:165-74.
18. Son MJ, Woolard K, Nam DH, Lee J, Fine HA. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 2009;4:440-52.
19. Ergün S, Kilik N, Ziegeler G, Hansen A, Nollau P, Götze J, et al. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 2000;5:311-20.
20. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, et al. Stat3 as an oncogene. Cell 1999;98:295-303.
21. Silva CM. Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 2004;23:8017-23.
22. Liu Y, Li C, Lin J. STAT3 as a therapeutic target for glioblastoma. Anticancer Agents Med Chem 2010;10:512-9.
23. Carpenter RL, Lo HW. STAT3 target genes relevant to human cancers. Cancers 2014;6:897-925.
24. Schäfer A, Teufel J, Ringel F, Bettstetter M, Hoepner I, Rasper M, et al. Aldehyde dehydrogenase 1A1-a new mediator of resistance to temozolomide in glioblastoma. Neuro Oncol 2012;14:1452-64.
25. Müller MM, Klaile E, Vorontsova O, Singer BB, Obrink B. Homophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-Src. J Cell Biol 2009;187:569-81.
26. Qu CK, Yu WM, Azzarelli B, Feng GS. Genetic evidence that Shp-2 tyrosine phosphatase is a signal enhancer of the epidermal growth factor receptor in mammals. Proc Natl Acad Sci U S A 1999;96:8528-33.
27. You M, Yu DH, Feng GS. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 1999;19:2416-24.
28. You M, Flick LM, Yu D, Feng GS. Modulation of the nuclear factor kappa B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor. J Exp Med 2001;193: 101-10.
29. Chong ZZ, Maiese K. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol 2007;22:1251-67.
30. Markel G, Lieberman N, Katz G, Arnon TI, Lotem M, Drize O, et al. CD66a interactions between humanmelanoma and NK cells: a novel class IMHCindependent inhibitory mechanism of cytotoxicity. J Immunol 2002;168: 2803-10.
31. Horst AK, Ito WD, Dabelstein J, Schumacher U, Sander H, Turbide C, et al. Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. J Clin Invest 2006;116: 1596-605.
32. Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE. Evidence of IL-18 as a novel angiogenic mediator. J Immunol 2001;167: 1644-53.
33. Metheny-Barlow LJ, Li LY. The enigmatic role of angiopoietin-1 in tumor angiogenesis. Cell Res 2003;13:309-17.
34. Fischer-Colbrie R, Kirchmair R, Kähler CM, Wiedermann CJ, Saria A. Secretoneurin: a new player in angiogenesis and chemotaxis linking nerves, blood vessels and the immune system. Curr Protein Pept Sci 2005;6:373-85.
35. Lucka L, Fernando M, Grunow D, Kannicht C, Horst AK, Nollau P, et al. Identification of Lewis x structures of the cell adhesion molecule CEACAM1 from human granulocytes. Glycobiology 2005;15: 87-100.
36. Bogoevska V, Horst A, Klampe B, Lucka L, Wagener C, Nollau P. CEACAM1, an adhesion molecule of human granulocytes, is fucosylated by fucosyltransferase IX and interacts with DC-SIGN of dendritic cells via Lewis x residues. Glycobiology 2006;16:197-209.
37. Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A 1978;75: 5565-9.
38. Fox N, Damjanov I, Martinez-Hernandez A, Knowles BB, Solter D. Immunohistochemical localization of the early embryonic antigen (SSEA-1) in postimplantation mouse embryos and fetal and adult tissues. Dev Biol 1981;83:391-8.
39. Capela A, Temple S. LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron 2002;35:865-75.
40. Patru C, Romao L, Varlet P, Coulombel L, Raponi E, Cadusseau J, et al. CD133, CD15/SSEA-1, CD34 or side populations do not resume tumorinitiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors. BMC Cancer 2010;10:66.
41. Nakajima A, Iijima H, Neurath MF, Nagaishi T, Nieuwenhuis EE, Raychowdhury R, et al. Activation-induced expression of carcinoembryonic antigen cell adhesion molecule 1 regulates mouse T lymphocyte function. J Immunol 2002;168:1028-35.
42. Doetsch F, Caillé I, Lim DA, García-Verdugo JM, Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999;97:703-16.
43. Chojnacki AK, Mak GK, Weiss S. Identity crisis for adult periventricular neural stem cells: subventricular zone astrocytes, ependymal cells or both? Nat Rev Neurosci 2009;10:153-63.
44. Poy MN, Ruch RJ, Fernstrom MA, Okabayashi Y, Najjar SM. Shc and CEACAM1 interact to regulate themitogenic action of insulin. J Biol Chem 2002;277:1076-84.
45. Abou-Rjaily GA, Lee SJ, May D, Al-Share QY, Deangelis AM, Ruch RJ, et al. CEACAM1 modulates epidermal growth factor receptor-mediated cell proliferation. J Clin Invest 2004;114:944-52.
46. Bousquet C, Susini C, Melmed S. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. J Clin Invest 1999;104:1277-85.
47. Arabzadeh A, Chan C, Nouvion AL, Breton V, Benlolo S, De Marte L, et al. Host-related carcinoembryonic antigen cell adhesion molecule 1 promotes metastasis of colorectal cancer. Oncogene 2013;32:849-60.
48. Prosniak M, Harshyne LA, Andrews DW, Kenyon LC, Bedelbaeva K, Apanasovich TV, et al. Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers. Clin Cancer Res 2013;19:3776-86.
49. Garofalo S, D'Alessandro G, Chece G, Brau F, Maggi L, Rosa A, et al. Enriched environment reduces glioma growth through immune and nonimmune mechanisms in mice. Nat Commun 2015;6:6623.